Cystic Kidney &
Ciliopathy Proteins

Good instinct if you thought "cystic kidney = fibrocystin." But think about when fibrocystin causes disease: infancy. Fibrocystin is ARPKD, which presents in newborns with Potter sequence. A 47-year-old could not have sailed through four decades with undiagnosed ARPKD. That ship sank at birth. Fibrocystin = baby disease. Polycystin = adult disease.

Nephrocystin causes nephronophthisis, which goes for medullary cysts and small kidneys, hits in childhood, and does not cause bilateral 22-cm kidneys you can feel from across the room. Also no family history of brain bleeds with nephronophthisis. Nephrocystin = small medullary cysts, not giant flanks.

Neurofibromin is a tumor suppressor that keeps Ras in check. You'd diagnose NF1 by looking at the patient, not the kidneys: cafe-au-lait spots the size of coffee stains, little lumps under the skin (neurofibromas), and iris nodules that look like tiny caramel candies (Lisch nodules). Not cystic kidneys. Neurofibromin does not cause cystic kidney disease. Ever.

Inversin is the protein for nephronophthisis type 2 (NPHP2). It can present with situs inversus (organs on the wrong side) because it also plays a role in left-right axis determination. This patient has giant bilateral kidneys in a 47-year-old, not medullary cysts in a child. Inversin = NPHP2, not ADPKD.

PKD1 gives you ADPKD, which is the dominant version that waits until adulthood. Think of it like a dominant personality: it makes itself known on its own schedule (usually 30s-50s). A newborn with oligohydramnios and respiratory distress is not an ADPKD presentation. PKD1 = adult onset. This baby needs the recessive version.

Nephronophthisis from NPHP1 mutations causes small medullary cysts in older children, not enormous echogenic kidneys in a newborn. There would also be no Potter sequence because nephronophthisis does not cause severe fetal renal failure. NPHP1 = medullary, childhood. Not neonatal enlarged kidneys.

NF1 is a tumor suppressor mutation. No polycystic kidneys, no oligohydramnios, no Potter sequence. Why do boards keep listing this? Because they want to see if you know the difference between ciliopathy proteins and tumor suppressors. You do now. Neurofibromin = NF1, not kidney cysts. Stop falling for this.

Polycystin-1 causes ADPKD. The family history would be positive (autosomal dominant = parent affected). The kidneys would be enormous and cortical cysts, not medullary. And the patient would be in their 40s, not 17. Every clue in this stem points away from polycystin-1. ADPKD = huge kidneys + family history + adult. This is none of those.

Fibrocystin is for ARPKD, presenting at birth. A 17-year-old with newly found renal insufficiency cannot have ARPKD, because an ARPKD patient at 17 either got a transplant years ago or didn't make it. Also, ARPKD kidneys are giant and echogenic, not normal-sized with medullary cysts. Fibrocystin = newborn. Not a teenage surprise diagnosis.

If you are still picking neurofibromin for kidney cysts, read this slowly: neurofibromin makes a protein that tells Ras to stop. It is a Ras-GAP. It has nothing to do with the primary cilium or cystic kidney disease. The only place neurofibromin belongs on this list is as the answer to "which of the following is NOT a ciliopathy protein." Neurofibromin = tumor suppressor, NF1. Not cystic kidneys. Not ciliopathy. Full stop.

Polycystin-1 is literally the most iconic cilium protein on this list. It forms a complex with polycystin-2 at the base of the primary cilium, acting as a mechanosensory calcium channel. It is the definition of a ciliopathy protein. Polycystin-1 IS a ciliopathy protein.

Fibrocystin localizes to the primary cilium and centrosome of tubular epithelial cells. When it fails, the cilium cannot properly signal and ARPKD develops. Fibrocystin IS a ciliopathy protein. Fibrocystin belongs with the ciliopathy family.

Inversin is the NPHP2 gene product and localizes to the primary cilium and cell-cell junctions. It has an extra role in left-right axis determination, which is why NPHP2 patients can have situs inversus. But it is absolutely a ciliopathy protein. Inversin is a legit ciliopathy protein for NPHP2.

Good instinct, both involve the liver, but congenital hepatic fibrosis is the liver complication of ARPKD (fibrocystin), not ADPKD. In ADPKD, you get hepatic cysts (fluid-filled, not fibrotic) and portal hypertension is not typical. The hepatic fibrosis + portal hypertension setup belongs to the recessive baby version. Hepatic fibrosis = ARPKD. ADPKD = hepatic cysts, not fibrosis.

Cafe-au-lait spots and nerve sheath tumors are NF1. Neurofibromatosis has nothing to do with polycystic kidney disease. If you are in a patient with PKD and you are somehow worried about cafe-au-lait spots, you are in the wrong disease. NF1 features have no place in ADPKD.

Situs inversus is found in nephronophthisis type 2 (NPHP2/inversin), because inversin plays a role in establishing left-right body axis. ADPKD (polycystin-1) has no connection to organ laterality. Situs inversus = inversin = NPHP2. Not ADPKD.

Mitochondria handle energy production. Mitochondrial diseases cause things like MELAS syndrome, ophthalmoplegia, myopathy, and lactic acidosis. They are not the mechanosensory organelle for tubular fluid flow. Mitochondria produce ATP. They do not detect flow in the tubule.

The ER handles protein synthesis, folding, and calcium storage. It does not project out of the cell surface to detect tubular flow. This is not the shared organelle of cystic kidney disease. ER = protein factory and calcium store. Not a flow sensor.

Close, but incomplete. The centrosome serves as the basal body from which the primary cilium grows. The ciliopathy proteins localize to the cilium itself (and the basal body), but the functional mechanosensory structure that actually bends in the tubule is the cilium, not the centrosome. The question asks about the shared sensory organelle. The primary cilium bends in flow. The centrosome anchors it. The cilium IS the antenna.

Both PKD1 and PKD2 mutations cause the same extrarenal complications: berry aneurysms, hepatic cysts, mitral valve prolapse. The difference is timeline and severity, not the type of complications. Both PKD types = same extrarenal complications, just different severity.

If anything, PKD1 causes larger kidneys faster due to more aggressive cyst growth. PKD2 patients tend to have slower cyst growth and smaller kidney volume. You would not expect smaller kidneys in PKD1. PKD1 = larger kidneys faster, not smaller.

That describes PKD2, the milder form. PKD1 presents earlier, with diagnosis often in the 30s-50s and ESRD by the 50s. PKD2 is the one that might not become apparent until later in life. Late presentation = PKD2. Early, severe = PKD1.

Polycystin-1 causes ADPKD: enormous kidneys in adults, family history, berry aneurysms, no situs inversus. A 3-year-old with normal kidney function and situs inversus is absolutely not ADPKD. Polycystin-1 = adult, big kidneys, SAH risk. Not situs inversus.

Fibrocystin causes ARPKD: giant kidneys at birth, Potter sequence, congenital hepatic fibrosis. At 3 years old with kidney function still normal, the presentation is too mild for fibrocystin/ARPKD. Also, ARPKD does not cause situs inversus. Fibrocystin = neonatal giant kidneys + Potter. Not situs inversus.

Nephrocystin (NPHP1) causes nephronophthisis type 1 with medullary cysts and childhood ESRD but does NOT cause situs inversus. Situs inversus is the specific extra trick that belongs to inversin (NPHP2), because inversin also controls left-right axis establishment during development. NPHP1 does NOT cause situs inversus. That distinction belongs to NPHP2/inversin.